Case Study: Aimmune Therapeutics boosts awareness of PALFORZIA with RAPP

Aimmune Therapeutics boosts PALFORZIA website traffic 154% with RAPP

The customer, Aimmune Therapeutics, faced the challenge of raising awareness for their FDA-approved peanut allergy treatment, PALFORZIA, among parents and caregivers of children with allergies who felt anxious and powerless. The vendor RAPP was tasked with introducing this new treatment option to the target audience.

RAPP implemented a targeted direct-to-consumer campaign with a media strategy powered by OMD. The solution focused on helping families "take the power back from peanuts." This campaign successfully increased PALFORZIA website traffic by approximately 154% per month, boosted user engagement by 73%, and saw returning traffic grow by 1,006%. Most importantly, RAPP's work provided renewed assurance to anxious children and their caregivers.

Aimmune Therapeutics